Sernova (TSE:SVA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova Corp., a biotech firm engaged in developing cell therapies for chronic diseases, has announced Jonathan Rigby as its new CEO. Rigby, who has a successful track record in raising capital and leading biotech companies to strategic acquisitions, is committed to advancing Sernova’s mission, particularly its leading project, the Cell Pouch System for a ‘functional cure’ in type 1 diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
